-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/sDqbgrKcUkE2J9uCJnH_q7
September 01, 2023 - understand specific permission, provided it is reproduced without any
the evidence but individualize decision … Clinicians should understand
the evidence but individualize decision making to the specific
patient
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/QH2JxjAo7FmcfCBy8c_65Y
November 18, 2024 - • The decision to breastfeed is a personal one and often affected by many social, cultural, and structural … important that the interventions be supportive, have
multiple touchpoints, and reflect that the decision
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/E24AtkYp7cR8bp864K4CGS
January 01, 2025 - Clinicians should understand
the evidence but individualize decision making to the specific
patient … Clinicians should understand
the evidence but individualize decision making to the specific
patient
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/QbeUNAqhpWwUetvo7sQ4D5
October 01, 2022 - Clinicians should understand the evidence but
individualize decision making to the specific patient … Clinicians should understand the evidence but
individualize decision making to the specific patient
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZLDgVoLvb--9ooeW9o5n8f
April 01, 2021 - Clinicians should understand the evidence but individualize decision making to the specific patient or … Clinicians should understand the evidence but individualize decision making to the specific patient or
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/tmpufJqkzbptG4uBtSGnam
September 01, 2022 - Clinicians should understand the evidence but 1
individualize decision making to the specific patient … Clinicians should understand the evidence but 2
individualize decision making to the specific patient
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-modeling-report/colorectal-cancer-screening3
October 27, 2020 - Return to In Progress page
Expand All
Colorectal Cancer Screening: A Decision
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-report/colorectal-cancer-screening
May 18, 2021 - to Recommendation
Expand All
Colorectal Cancer Screening: An Updated Decision
-
www.uspreventiveservicestaskforce.org/uspstf/lets-talk-about-it-screening-breast-cancer
May 03, 2025 - This guide is not intended to serve as a risk assessment tool or decision aid.
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-modeling-report/aspirin-use-to-prevent-cardiovascular-disease-preventive-medication
October 12, 2021 - All
Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: An Updated Decision
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/WB-VZpzKsTPjEBnb27gCuf
January 01, 2024 - understand specific permission, provided it is reproduced without any
the evidence but individualize decision … Clinicians should understand
the evidence but individualize decision making to the specific
patient
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-modeling-report/breast-cancer-screening-adults
May 09, 2023 - Expand All
Panel 1
Breast Cancer Screening With Mammography: An Updated Decision
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-modeling-report/aspirin-to-prevent-cardiovascular-disease-preventive-medication
April 26, 2022 - Panel 1
Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: An Updated Decision
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/LPaUxRbrTshfsYVVTzenEQ
April 26, 2022 - RECOMMENDATION The decision to initiate low-dose aspirin use for the primary prevention of
CVD in adults … Adults aged 40 to 59 years with
a 10% or greater 10-year
cardiovascular disease (CVD) risk
The decision … • Aspirin should be initiated selectively based on individual decision-making rather than routinely … The decision to initiate low-dose aspirin use for the primary prevention of CVD in this group should … The USPSTF recommends that the decision to initiate low-dose as-
pirin use for the primary prevention
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-to-prevent-cardiovascular-disease-preventive-medication
April 26, 2022 - Adults aged 40 to 59 years with a 10% or greater 10-year cardiovascular disease (CVD) risk
The decision … aged 40 to 59 years with an estimated 10% or greater 10-year cardiovascular disease (CVD) risk: The decision … Aspirin should be initiated selectively based on individual decision-making rather than routinely for … In patients whose estimated CVD risk is 10% or greater, use shared decision-making, taking into account … Clinicians should understand the evidence but individualize decision-making to the specific patient or
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis/hiv-prep-discussion-guide-clinicians-and-patients
May 08, 2022 - This guide is not intended to serve as a risk assessment tool or decision aid.
-
www.uspreventiveservicestaskforce.org/uspstf/hiv-prep-discussion-guide-clinicians-and-patients
June 01, 2019 - This guide is not intended to serve as a risk assessment tool or decision aid.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/CgLQsDuh3LaDVGNWRX9CUP
April 01, 2025 - understand specific permission, provided it is reproduced without any
the evidence but individualize decision … Clinicians should understand
the evidence but individualize decision making to the specific
patient
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/AatJtxMVkZmYocHovSanQ4
June 01, 2024 - Clinicians should understand
the evidence but individualize decision making to the specific
patient … Clinicians should understand
the evidence but individualize decision making to the specific
patient
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/zYdjLaTCTBVUwgJTnzpVXr
May 08, 2018 - The USPSTF also commissioned a review of existing decision analysis models
and the overdiagnosis rate … CONCLUSIONS AND RECOMMENDATION For men aged 55 to 69 years, the decision to undergo
periodic PSA-based … Clinicians should understand
the evidence but individualize decision making to the specific
patient or … Summary of Recommendations and Evidence
For men aged 55 to 69 years, the decision to undergo periodic … The decision about whether to be screened for prostate cancer
requires that each man incorporate his